Devyser signs first commercial reagent rental agreement under Illumina collaboration in Italy
Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial...
News | May 4, 2016
Devyser Holding AB announced at its annual general meeting yesterday the appointment of two new board members, Ernst Westman and Lars Höckenström.
Ernst Westman is CEO of the boule diagnostics group since 22 years. Lars Höckenström is currently a senior adviser at Stockholm corporate finance. Chairman of the board Mia Arnhult comments:
"I am delighted to have Ernst Westman and Lars Höckenström on Devyser’s board. Their combined experience and expertise within both the diagnostics industry and finance will greatly benefit our work.
Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial...
Read More
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a tender in...
Read More
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Read More